<DOC>
	<DOCNO>NCT03000673</DOCNO>
	<brief_summary>To investigate safety Single Doses BMS-986177 Patients End Stage Renal Disease treat hemodialysis</brief_summary>
	<brief_title>A Study Evaluate Safety Single Doses BMS-986177 Patients With End Stage Renal Disease ( ESRD ) Treated With Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>For information regard BristolMyers Squibb Clinical Trial participation , please visit www.BMSStudyConnect.com Subjects ESRD treat hemodialysis 3 time week least 3 month prior enrollment . Women childbearing potential ( WOCBP ) must negative serum urine pregnancy test ( minimum sensitivity 25 IU/L equivalent unit HCG ) within 24 hour prior start study treatment . Women must breastfeed Women childbearing potential ( WOCBP ) must agree follow instruction method ( ) contraception duration treatment study treatment ( ) BMS986177 plus 5 halflives study treatment ( 2 day ) plus 30 day ( duration ovulatory cycle ) total 32 day posttreatment completion Males sexually active WOCBP must agree follow instruction method ( ) contraception duration treatment study treatment ( ) BMS986177 plus 5 halflives study treatment plus 90 day ( duration sperm turnover ) total 92 day posttreatment completion . In addition , male participant must willing refrain sperm donation time . Subjects receive dialysis central venous catheter History uncontrolled unstable cardiovascular , respiratory , hepatic , gastrointestinal , endocrine , hematopoietic , psychiatric and/or neurological disease past 3 month Current recent ( within 3 month study drug administration ) gastrointestinal disease surgery , judgment Investigator , may increase subject 's risk gastrointestinal bleeding interfere absorption study drug ( e.g. , peptic gastric ulcer disease , severe gastritis , history gastrointestinal surgery ) . Any major surgery within 12 week study drug administration History significant head injury within last 2 year , include subject base skull fracture Other protocol define inclusion/exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>